Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytosorbents (CTSO) Preferred Dividend Payments (2017)

Historic Preferred Dividend Payments for Cytosorbents (CTSO) over the last 5 years, with Q4 2017 value amounting to -$671462.0.

  • Cytosorbents' Preferred Dividend Payments changed N/A to -$671462.0 in Q4 2017 from the same period last year, while for Dec 2018 it was -$671462.0, marking a year-over-year change of 0.0%. This contributed to the annual value of -$335731.0 for FY2017, which is N/A changed from last year.
  • Per Cytosorbents' latest filing, its Preferred Dividend Payments stood at -$671462.0 for Q4 2017.
  • In the past 5 years, Cytosorbents' Preferred Dividend Payments ranged from a high of $13.3 million in Q4 2013 and a low of -$671462.0 during Q4 2017
  • Its 3-year average for Preferred Dividend Payments is $2.3 million, with a median of $865502.0 in 2013.
  • As far as peak fluctuations go, Cytosorbents' Preferred Dividend Payments tumbled by 1660.68% in 2013, and later surged by 14394.23% in 2014.
  • Cytosorbents' Preferred Dividend Payments (Quarter) stood at $13.3 million in 2013, then tumbled by 90.38% to $1.3 million in 2014, then crashed by 152.41% to -$671462.0 in 2017.
  • Its last three reported values are -$671462.0 in Q4 2017, $1.3 million for Q3 2014, and $1.4 million during Q2 2014.